Literature DB >> 26225077

Role of Rapid Tetanus Antibody Test in Accident and Emergency Department.

A Chithra1, K M Cariappa1, Abhay Taranath Kamath1, Adarsh Kudva1.   

Abstract

INTRODUCTION: Tetanus remains a problem of immense concern worldwide. Management of tetanus with its attendant complications are challenges to the physician and its prevention is the chief priority. The choice of tetanus prophylaxis for patients with wounds depends on obtaining their vaccination history, which has been demonstrated to be unreliable. The tetanus antibody test may avoid inadequate prophylactic measures and reduce costs.
PURPOSE: This study is conducted to determine the feasibility of rapid tetanus antibody test (SD Bioline) in the accident and emergency department.
METHODS: A randomized prospective study was conducted on 50 patients, divided into two groups-A and B with 25 patients each respectively. Group A had patients with a history of tetanus immunization <5 years elapsed from the last booster dose. Group B had patients who did not know the immunization status or more than 5 years elapsed from the last booster dose of tetanus immunization. Groups A and B were further classified into Group 1 and Group 2 based on whether the wound is tetanus prone or a clean wound respectively. Tetanus antibody test was done using whole-blood from the patients by finger prick.
RESULTS: Among the 50 patients, 25 (50 %) were classified as 'unprotected' according to the history. Thirteen of the 25 patients showed tetanus antibody positive. In Group A, only 9 of the 25 patients showed tetanus antibody positive.
CONCLUSION: The rapid tetanus antibody test in the emergency room could make tetanus prevention more accurate with improved technical feasibility. The test may eliminate unnecessary injecting of vaccine, reduce the cost and can be performed at the hospital setting.

Entities:  

Keywords:  Emergency; Tetanus; Wounds

Year:  2014        PMID: 26225077      PMCID: PMC4510086          DOI: 10.1007/s12663-014-0695-8

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  8 in total

1.  TETANUS IN TREATMENT OF PATIENTS WITH MULTIPLE TRAUMA.

Authors:  L H KURTZ
Journal:  J Natl Med Assoc       Date:  1964-03       Impact factor: 1.798

2.  Diagnosis of tetanus immunization status: multicenter assessment of a rapid biological test.

Authors:  Isabelle Colombet; Colette Saguez; Marie-José Sanson-Le Pors; Benoît Coudert; Gilles Chatellier; Pierre Espinoza
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

3.  [Evaluation of SD BIOLINE tetanus kit].

Authors:  Jee-Eun Lee; Soo-Youn Lee
Journal:  Korean J Lab Med       Date:  2007-06

4.  Improving tetanus prophylaxis in the emergency department: a prospective, double-blind cost-effectiveness study.

Authors:  Muriel Stubbe; Luc J M Mortelmans; Didier Desruelles; Rohnny Swinnen; Marc Vranckx; Edmond Brasseur; Philippe E Lheureux
Journal:  Emerg Med J       Date:  2007-09       Impact factor: 2.740

Review 5.  Tetanus.

Authors:  R Bhatia; S Prabhakar; V K Grover
Journal:  Neurol India       Date:  2002-12       Impact factor: 2.117

Review 6.  Antimicrobial prophylaxis for wounds and procedures in the emergency department.

Authors:  Gregory J Moran; David A Talan; Fredrick M Abrahamian
Journal:  Infect Dis Clin North Am       Date:  2008-03       Impact factor: 5.982

7.  Pretravel consultation: rapid dipstick test as a decision guidance for the application of tetanus booster vaccinations.

Authors:  Maria Paulke-Korinek; Pamela Rendi-Wagner; Michael Kundi; Batya Tomann; Ursula Wiedermann; Herwig Kollaritsch
Journal:  J Travel Med       Date:  2008 Nov-Dec       Impact factor: 8.490

8.  Rapid quantitative microenzyme-linked immunosorbent assay for tetanus antibodies.

Authors:  A K Sedgwick; M Ballow; K Sparks; R C Tilton
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

  8 in total
  1 in total

1.  Tetanus vaccination, antibody persistence and decennial booster: a serosurvey of university students and at-risk workers.

Authors:  M Borella-Venturini; C Frasson; F Paluan; D DE Nuzzo; G DI Masi; M Giraldo; F Chiara; A Trevisan
Journal:  Epidemiol Infect       Date:  2017-03-15       Impact factor: 4.434

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.